과제정보
연구 과제 주관 기관 : Uludag University of Turkey
참고문헌
- Allegra A, Alonci A, Campo S, et al (2012). Circulating microRNA: New biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol, 41, 1897-912. https://doi.org/10.3892/ijo.2012.1647
- Aquilar F, Ramirez JA, Malagon-Santiago I, et al (2013). Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Disease Markers, 34, 163-169. https://doi.org/10.1155/2013/259454
- Asaga S, Kuo C, Nguyen T, et al (2011). Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem, 57, 84-91. https://doi.org/10.1373/clinchem.2010.151845
- Calin GA, Croce CM, (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Chan M, Liaw CS, Ji SM, (2013). Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res, 19, 4477-87. https://doi.org/10.1158/1078-0432.CCR-12-3401
- Chen G, Wang J, Cui Q, (2013). Could circulating miRNAs contribute to cancer therapy? Trends Mol Med, 19, 71-3. https://doi.org/10.1016/j.molmed.2012.10.006
- Corcoran C, Friel AM, Duffy MJ, et al (2011). Intracellular and extracellular MicroRNAs in breast cancer. Clin Chem, 57, 18-32. https://doi.org/10.1373/clinchem.2010.150730
- Cortez MA, Welsh JW, Calin GA, (2012). Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res, 195, 151-61.
- Creighton CJ, (2012). The molecular profile of luminal B breast cancer. Biologics: Targets Therapy, 6, 289-97.
- Cuk K, Zucknick M, Heil J, et al (2013). Circulating micrornas in plasma as early detection markers for breast cancer. Int J Cancer, 132, 1602-12. https://doi.org/10.1002/ijc.27799
- Demirdogen Sevinc E, Egeli U, Cecener G, et al (2015). Association of miR-1266 with Recurrence/Metastasis Potential in Estrogen Receptor Positive Breast Cancer. Asian Pac J Cancer Prev, 16, 291-7 https://doi.org/10.7314/APJCP.2015.16.1.291
- Desantis C, Ma J, Bryan L, et al (2014). Breast cancer statistics. CA Cancer J Clin, 64, 52-62. https://doi.org/10.3322/caac.21203
- EK Ng, Li R, Shin VY, et al (2013). Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One, 8, 531-41.
- Erturk E, Cecener G, Egeli U, et al (2014). Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations. Mol Cell Biochem, 395, 77-88. https://doi.org/10.1007/s11010-014-2113-4
- Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics, 9, 102-14. https://doi.org/10.1038/nrg2290
- He L, Hannon GJ (2004). MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev Genet, 5, 522-31. https://doi.org/10.1038/nrg1379
- Heneghan HM, Miller N, Kelly R, et al (2010). Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist, 15, 673-82. https://doi.org/10.1634/theoncologist.2010-0103
- Heneghan HM, Miller N, Kerin MJ, (2011). Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res, 13, 402. https://doi.org/10.1186/bcr2798
- Heneghan HM, Miller N, Lowery AJ, et al (2010). Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg, 251, 499-505. https://doi.org/10.1097/SLA.0b013e3181cc939f
- Iorio MV, Casalini P, Tagliabue E, et al (2008). MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. European J Cancer, 44, 2753-9. https://doi.org/10.1016/j.ejca.2008.09.037
- Iorio MV, Ferracin M, Liu CG, (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. https://doi.org/10.1158/0008-5472.CAN-05-1783
- Jack RH, Davies EA, Renshaw C, et al (2013). Differences in breast cancer hormone receptor status in ethnic groups: A London population. Eur J Cancer, 49, 696-702. https://doi.org/10.1016/j.ejca.2012.09.012
- Kavitha N, Vijayarathna S, Jothy SL, et al (2014). MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis. Asian Pac J Cancer Prev, 15, 7489-97. https://doi.org/10.7314/APJCP.2014.15.18.7489
- Kayani MR, Kayani MA, Malik FA et al (2011). Role of miRNAs in breast cancer. Asian Pacific J Cancer Prev, 12, 3175-80.
- Kosaka N, Iguchi H, Ochiya T, (2010). Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci, 101, 2087-92. https://doi.org/10.1111/j.1349-7006.2010.01650.x
-
Livak KJ, Schmittgen T.D, (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-
${\Delta}{\Delta}CT$ ) method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262 - Lowery AJ, Miller N, McNeill RE, et al (2008). MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res, 14, 360-5. https://doi.org/10.1158/1078-0432.CCR-07-0992
- Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
- Luo Q, Wei C, Li X, et al (2014). MicroRNA-195-5p is a potential diagnostic and therapeutic target for breast cancer. Oncol Reps, 31, 1096-102. https://doi.org/10.3892/or.2014.2971
- Ma R, Jiang T, Kang X (2012). Circulating microRNAs in cancer: origin, function and application. JECCR, 31, 38.
- Ma R, Jiang T, Kang X (2012). Circulating microRNAs in cancer: origin, function and application. J Exp Clin Can, 31, 38. https://doi.org/10.1186/1756-9966-31-38
- Madhavan D, Cuk K, Burwinkel B, et al (2013). Cancer diagnosis and prognosis decoded by blood-based circulating microRNA signatures. FGENE, 4.
- Madhavan D, Zucknick M, Wallwiener M, et al (2012). Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin Cancer Res, 18, 5972-82. https://doi.org/10.1158/1078-0432.CCR-12-1407
- Mirnezami AH, Pickard K, Zhang L, et al (2009). MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol, 3, 339-47.
- Qu H, Xu W , Huang Y et al (2011). Circulating miRNAs: promising biomarkers of human cancer. Asian Pac J Cancer Prev, 12, 1117-25.
- Roth C, Rack B, Muller V, et al (2010). Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res, 12.
- Roth C, Rack B, Muller V, et al (2010). Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer. Breast Cancer Res, 12, 90. https://doi.org/10.1186/bcr2766
- Sarfati D, Blakely T, Shaw C, et al (2006). Patterns of disparity: ethnic and socio-economic trends in breast cancer mortality in New Zealand. Cancer Causes Control, 17, 671-8. https://doi.org/10.1007/s10552-005-0583-0
- Schrauder MG, Strick R, Schulz-Wendtland R, et al (2012). Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One, 7, 1-9.
- Shavers VL, Brown ML, (2002). Racial and ethnic disparities in the receipt of cancer treatment. J National Cancer Inst, 94, 334-57. https://doi.org/10.1093/jnci/94.5.334
- Shavers VL, Brown M.L, (2002). Racial and ethnic disparities in the receipt of cancer treatment. J National Cancer Inst, 94, 334-57. https://doi.org/10.1093/jnci/94.5.334
- Shen J, Ambrosone CB, DiCioccio RA, et al (2008). A functional polymorphism in the miR-146a gene and age of familialbreast/ovarian cancer diagnosis. Carcinogenesis, 29, 1963-66. https://doi.org/10.1093/carcin/bgn172
- Si H, Sun X, Chen Y, et al (2013). Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol, 139, 223-9. https://doi.org/10.1007/s00432-012-1315-y
- Sun Y, Wang M, Lin G, et al (2012). Serum microRNA-155 as a potential biomarker to track disease in breast cancer. PLoS One, 7.
- Uchida N, Suda T, et al (2013). Effect of chemotherapy for Luminal A breast cancer. Acta Med, 56, 51-6.
- Vasudevan S, Tong YC, Steitz JA, (2007). Switching from repression to activation: MicroRNAs can up-regulate translation. Sci, 318, 1931-34. https://doi.org/10.1126/science.1149460
- Wang H, Tan G, Dong L, et al (2012). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One, 7.
- Wang J, Zhang K, Liu S, et al (2014). Tumor-associated circulating microRNAs as biomarkers of cancer. Molecules, 19, 1912-38. https://doi.org/10.3390/molecules19021912
- Wiencke JK (2004). Impact of race/ethnicity on molecular pathways in human cancer. Nat Rev Cancer, 4, 79-84. https://doi.org/10.1038/nrc1257
- Wu Q, Lu Z, Li H, et al (2011). Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol.
- Wu X, Somlo G, Yu Y, et al (2012). De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer. J Transl Med, 10, 42. https://doi.org/10.1186/1479-5876-10-42
- Yanagawa M, Ikemot K, Kawauchi S, et al (2012). Luminal A and Luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotypes. BMC Research Notes, 5, 376. https://doi.org/10.1186/1756-0500-5-376
- Zhang H, Su B, Zhou QM, et al (2009). Differential expression